Drug intelligence / Profile preview

lidan pian

Development stage: Unknown
Lead developer: Qingdao Growful Pharmaceutical
Administration: Oral

Overview

Lidan Pian is a Traditional Chinese Medicine (TCM) formulation primarily indicated for the treatment of hepatobiliary conditions, including acute and chronic cholecystitis and cholangitis. Manufactured by Shanghai Pharmaceuticals Group Qingdao Growful Pharmaceutical, the product is marketed as an over-the-counter (OTC) tablet in China. The formulation typically consists of a blend of herbal extracts, such as *Scutellaria baicalensis* (Baical Skullcap) and *Lonicera japonica* (Honeysuckle), which work synergistically to clear heat, resolve dampness, and promote bile secretion (choleretic effect). It is used to alleviate symptoms such as right upper quadrant pain, fever, and jaundice associated with gallbladder inflammation and biliary tract disorders.

Brand names: Lidan Pian
Other names: 利胆片

Beyond the preview

Go deeper on lidan pian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidan pian.

Explore the full profile